In vitro and In vivo Investigation of poly(lactic acid)/hydroxyapatite nanoparticle scaffold containing nandrolone decanoate for the regeneration of critical-sized bone defects

Document Type : Research Paper

Authors

1 Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

2 Tissue Engineering and Stem Cells Research Center, Shahroud University of Medical Sciences, Shahroud, Iran

3 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Mechanical and Aerospace Engineering, Islamic Azad University, Science and Research Branch, Tehran, Iran

5 Department of Biology, Islamic Azad University, Jahrom Branch, Jahrom, Iran

6 Dentistry Student, Scientific Research Center, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

7 Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 1417755469, Iran

8 Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran

9 Craniomaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran

10 Department of Oral and Maxillofacial Surgery, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

11 Department of Tissue Engineering, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran

Abstract

Objective(s): Bone tissue engineering is aimed at the fabrication of bone graft to ameliorate bone defects without using autografts or allografts.
Materials and Methods: In the present study, the coprecipitation method was used to prepare hydroxyapatite (HA) nanoparticles containing nandrolone. To do so, 12.5, 25, and 50 mg of nandrolone were loaded into poly(lactic acid) (PLA)/nano-HA, and the freeze casting method was used to fabricate porous scaffolds. The morphology, mechanical strength, wettability, porosity, degradation, blood compatibility, and cellular response of the scaffolds were evaluated using various tests. For further investigation, the developed scaffolds were incorporated into the rat calvaria defect model, and their effects on bone healing were evaluated.
Results: The obtained results indicated that the fabricated scaffolds had the approximate porosity of 80% and compress strength of 6.5 MPa. Moreover, the prepared scaffolds had appropriate hydrophilicity, weight loss, and blood compatibility. Furthermore, the histopathological findings demonstrated that the defects filled with the PLA/nano-HA scaffolds containing 25 mg nandrolone healed better compared to the other study groups.
Conclusion: Therefore, it was concluded that the scaffolds containing nandrolone could be used in bone regeneration.

Keywords

References

1.Guo B, Glavas L, Albertsson A-C. Biodegradable and electrically conducting polymers for biomedical applications. Prog Polym Sci. 2013; 38(9): 1263-1286.
2.Nabavi MH, Salehi M, Ehterami A, Bastami F, Semyari H, Tehranchi M, Nabavi MA, Semyari H. A collagen-based hydrogel containing tacrolimus for bone tissue engineering. Drug Deliv Transl Res. 2019: 1-14.
3.Semyari H, Salehi M, Taleghani F, Ehterami A, Bastami F, Jalayer T, Semyari H, Hamed Nabavi M, Semyari H. Fabrication and characterization of collagen–hydroxyapatite-based composite scaffolds containing doxycycline via freeze-casting method for bone tissue engineering. J Biomater Appl. 2018; 33(4): 501-513.
4.Salehi M, Bastami F. Characterization of wet-electrospun poly (ε-caprolactone)/poly (L-lactic) acid with calcium phosphates coated with chitosan for bone engineering. RRR 2016;1(2):69-74.
5.Ehterami A, Kazemi M, Nazari B, Saraeian P, Azami M. Fabrication and characterization of highly porous barium titanate based scaffold coated by Gel/HA nanocomposite with high piezoelectric coefficient for bone tissue engineering applications. J Mech Behav Biomed Mater. 2018; 79: 195-202.
6.Deville S, Saiz E, Tomsia AP. Freeze casting of hydroxyapatite scaffolds for bone tissue engineering. Biomater. 2006; 27(32): 5480-5489.
7.Farzamfar S, Naseri-Nosar M, Sahrapeyma H, Ehterami A, Goodarzi A, Rahmati M, Ahmadi Lakalayeh G, Ghorbani S, Vaez A, Salehi M. Tetracycline hydrochloride-containing poly (ε-caprolactone)/poly lactic acid scaffold for bone tissue engineering application: in vitro and in vivo study. Int J Polym Mater. 2019; 68(8): 472-479.
8.Alexandre M, Beyer G, Henrist C, Cloots R, Rulmont A, Jérôme R, Dubois P. “One-Pot” Preparation of Polymer/Clay Nanocomposites Starting from Na+ Montmorillonite. 1. Melt Intercalation of Ethylene− Vinyl Acetate Copolymer. Chem Mater. 2001; 13(11): 3830-3832.
9.Lee JH, Park TG, Park HS, Lee DS, Lee YK, Yoon SC, Nam J-D. Thermal and mechanical characteristics of poly (L-lactic acid) nanocomposite scaffold. Biomater. 2003; 24(16): 2773-2778.
10.Samadian H, Salehi M, Farzamfar S, Vaez A, Ehterami A, Sahrapeyma H, Goodarzi A, Ghorbani S. In vitro and in vivo evaluation of electrospun cellulose acetate/gelatin/hydroxyapatite nanocomposite mats for wound dressing applications. Artif Cells Nanomed Biotechnol. 2018; 46(sup1): 964-974.
11.Kumta PN, Sfeir C, Lee D-H, Olton D, Choi D. Nanostructured calcium phosphates for biomedical applications: novel synthesis and characterization. Acta Biomater. 2005; 1(1): 65-83.
12.Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, Hamada Y, Takahashi J. Hydroxyapatite particles as a controlled release carrier of protein. Biomater. 2004; 25(17): 3807-3812.
13.Mizushima Y, Ikoma T, Tanaka J, Hoshi K, Ishihara T, Ogawa Y, Ueno A. Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release. 2006; 110(2): 260-265.
14.Tamm T, Peld M. Computational study of cation substitutions in apatites. J Solid State Chem. 2006; 179(5): 1581-1587.
15.P Busardo F, Frati P, Di Sanzo M, Napoletano S, Pinchi E, Zaami S, Fineschi V. The impact of nandrolone decanoate on the central nervous system. Curr Neuropharmacol. 2015; 13(1):122-131.
16.Pardridge WM. 4 Serum bioavailability of sex steroid hormones. Best Pract Res Clin Endocrinol Metab. 1986; 15(2): 259-278.
17.Riezzo I, Turillazzi E, Bello S, Cantatore S, Cerretani D, Di Paolo M, Fiaschi AI, Frati P, Neri M, Pedretti M. Chronic nandrolone administration promotes oxidative stress, induction of pro-inflammatory cytokine and TNF-α mediated apoptosis in the kidneys of CD1 treated mice. Toxicol Appl Pharmacol. 2014; 280(1): 97-106.
18.Bahrke MS, Yesalis CE, Wright JE. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. Sports Med. 1996; 22(6): 367-390.
19.Buckley WE, Yesalis CE, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. Jama. 1988; 260(23): 3441-3445.
20.Durant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med Overseas Ed 1993;328(13):922-926.
21.Kopera H. The history of anabolic steroids and a review of clinical experience with anabolic steroids. Acta Endocrinol. 1985; 110(3 Suppla): S11-S18.
22.Eklöf A-C, Thurelius A-M, Garle M, Rane A, Sjöqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003; 59(8-9): 571-577.
23.Verroken M. Ethical aspects and the prevalence of hormone abuse in sport. J Endocrinol. 2001; 170(1): 49-54.
24.Sun L, Pan J, Peng Y, Wu Y, Li J, Liu X, Qin Y, Bauman WA, Cardozo C, Zaidi M. Anabolic steroids reduce spinal cord injury-related bone loss in rats associated with increased Wnt signaling. J Spinal Cord Med. 2013; 36(6): 616-622.
25.Ahmad F, Yunus SM, Asghar A, Faruqi N. Influence of anabolic steroid on tibial fracture healing in rabbits–a study on experimental model. J Clin Diagn Res. 2013; 7(1): 93.
26.Salehi M, Naseri-Nosar M, Ebrahimi-Barough S, Nourani M, Vaez A, Farzamfar S, Ai J. Regeneration of sciatic nerve crush injury by a hydroxyapatite nanoparticle-containing collagen type I hydrogel. Jpn J Physiol. 2018; 68(5): 579-587.
27.Tanaka K, Shiga T, Katayama T. Fabrication of hydroxyapatite/PLA composite nanofiber by electrospinning. High Performance and Optimum Design of Structures and Materials II. 2016; 166: 371.
28.Shahrezaee M, Salehi M, Keshtkari S, Oryan A, Kamali A, Shekarchi B. In vitro and in vivo investigation of PLA/PCL scaffold coated with metformin-loaded gelatin nanocarriers in regeneration of critical-sized bone defects. Nanomed. 2018; 14(7): 2061-2073.
29.Hannink G, Arts JC. Bioresorbability, porosity and mechanical strength of bone substitutes: what is optimal for bone regeneration? Inj. 2011; 42: S22-S25.
30.Karp JM, Shoichet MS, Davies JE. Bone formation on two‐dimensional poly (DL‐lactide‐co‐glycolide)(PLGA) films and three‐dimensional PLGA tissue engineering scaffolds in vitro. J Biomed Mater Res A. 2003; 64(2): 388-396.
31.Bose S, Roy M, Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 2012; 30(10): 546-554.
32.Bat E, Zhang Z, Feijen J, Grijpma DW, Poot AA. Biodegradable elastomers for biomedical applications and regenerative medicine. Regen Med. 2014; 9(3): 385-398.
33.Abbasian M, Massoumi B, Mohammad-Rezaei R, Samadian H, Jaymand M. Scaffolding polymeric biomaterials: Are naturally occurring biological macromolecules more appropriate for tissue engineering? Int J Biol Macromol. 2019.
34.Liao S, Cui F, Zhang W, Feng Q. Hierarchically biomimetic bone scaffold materials: nano‐HA/collagen/PLA composite. J Biomed Mater Res B. 2004; 69(2): 158-165.
35.Yoshikawa H, Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics. Art Org. 2005; 8(3): 131-136.
36.Akindoyo JO, Beg MD, Ghazali S, Heim HP, Feldmann M. Effects of surface modification on dispersion, mechanical, thermal and dynamic mechanical properties of injection molded PLA-hydroxyapatite composites. Compos A. 2017; 103: 96-105.
37.Wu C, Ramaswamy Y, Zhu Y, Zheng R, Appleyard R, Howard A, Zreiqat H. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly (DL-lactide-co-glycolide) films. Biomater. 2009; 30(12): 2199-2208.
38.Yuan J, Shen J, Kang IK. Fabrication of protein‐doped PLA composite nanofibrous scaffolds for tissue engineering. Polym Int. 2008; 57(10):1188-1193.
39.Fratzl P, Gupta H, Paschalis E, Roschger P. Structure and mechanical quality of the collagen–mineral nano-composite in bone. J Mater Chem. 2004; 14(14): 2115-2123.
40.Yuan H, Li Y, De Bruijn J, De Groot K, Zhang X. Tissue responses of calcium phosphate cement: a study in dogs. Biomater. 2000; 21(12): 1283-1290.
41.Kilpadi KL, Chang PL, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res A. 2001; 57(2): 258-267.
42.Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomater. 2005; 26(27): 5474-5491.
43.Boccaccio A, Uva AE, Fiorentino M, Bevilacqua V, Pappalettere C, Monno G. A Computational Approach to the Design of Scaffolds for Bone Tissue Engineering. Adv Biomater. 2018. p. 111-117.
44.Murphy CM, Haugh MG, O’Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen–glycosaminoglycan scaffolds for bone tissue engineering. Biomater. 2010; 31(3): 461-466.
45.Ramesh N, Moratti SC, Dias GJ. Hydroxyapatite–polymer biocomposites for bone regeneration: A review of current trends. J Biomed Mater Res B. 2018; 106(5): 2046-2057.
46.Huyck L, Ampe C, Van Troys M. The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix. Assay Drug Dev Technol. 2012; 10(4): 382-392.
47.Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer cell. 2008; 13(3): 188-192.
48.Vannucci L, Brandi ML. Healing of the bone with anti-fracture drugs. Expert Opin Pharmacother. 2016; 17(17): 2267-2272.
49.Demling RH. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen. 2000; 8(2): 97-102.
50.Guimarães APFGM, Butezloff MM, Zamarioli A, Issa JPM, Volpon JB. Nandrolone decanoate appears to increase bone callus formation in young adult rats after a complete femoral fracture. Acta Cir Bras. 2017; 32(11): 924-934.
51.Ogasawara A, Nakajima A, Nakajima F, Goto K-i, Yamazaki M. Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone. 2008; 43(5): 832-839.
52.Urabe K, Kim HJ, Sarkar G, Bronk JT, Bolander ME. Determination of the complete cDNA sequence of rat type II collagen and evaluation of distinct expression patterns of types IIA and IIB procollagen mRNAs during fracture repair in rats. Ortho Sci. 2003; 8(4): 585-590.
53.Pansieri JC, Esteves A, Junior WCR. Anabolic Steroids Effects on Bone Regeneration. Sport Sci. 2019; 7(3): 88-93.
Nanomedicine Journal
Volume 7, Issue 2
April 2020
Pages 115-123

Files

Share

How to cite

Statistics